CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
24 research outputs found
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Author
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
Publication venue
'American College of Physicians'
Publication date
Field of study
No full text
Crossref
Drug Therapies for Stroke Prevention in Atrial Fibrillation
Author
ACTIVE Investigators
Agarwal
+58Â more
Albers
Albert L. Waldo
Alexander
Atrial Fibrillation Investigators
Birman-Deych
Connolly
Connolly
Connolly
Connolly
Eikelboom
European Atrial Fibrillation Trial Investigators
European Heart Rhythm Association
Ezekowitz
Ezekowitz
Fang
Fang
Fang
Fisher
Flaker
Friberg
Fuster
Gage
Garcia
Go
Go
Granger
Hart
Hart
Hylek
Hylek
Hylek
Lip
Lopes
Mant
Nieuwlaat
Nieuwlaat
Olesen
Patel
Petersen
ROCKET AF Study Investigators
Ruff
Sato
Sherman
Singer
Singer
Skanes
The SPAF II Investigators
The SPAF III Investigators
The SPAF Investigators
van Walraven
Waldo
Walker
Wang
Wann
White
Wolf
Wyse
You
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients
Author
Connolly
G. Engel
+19Â more
Gage
Granger
Hellemons
M. H. Kong
Mant
Olesen
Olesen
Olesen
Olsson
R. A. Patrawala
R. A. Winkle
R. H. Mead
Rosand
Skanes
SPORTIF Executive Steering Committee for the SPORT
The SPAF III Writing Committee for the Stroke Prev
Van Staa
van Walraven
Wang
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref
Age and Risk of Stroke in Atrial Fibrillation: Evidence for Guidelines?
Author
Altman DG
Andersen TF
+18Â more
Benjamin EJ
Connolly SJ
EAFT (European Atrial Fibrillation Trial) Study Group
Ezekowitz MD
Go AS
John Godtfredsen
Johnsen SP
Korantzopoulos P
Lars Frost
Leif Spange Mortensen
Ljubica Vukelic Andersen
Mukamal KJ
National Institute of Neurological Disorders and
Nielsen HW
Stroke Prevention
The Boston Area Anticoagulation
The SPAF III
Wang TJ
Publication venue
'S. Karger AG'
Publication date
Field of study
No full text
Crossref
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation
Author
Albers
Ansell
+34Â more
Atrial fibrillation Investigators
Bradburn
Connolly
Connolly
Douketis
EAFT (European Atrial Fibrillation Trial) Study Group
Ezekowitz
Garcia
Go
Gulløv
Gulløv
Hellemons
Hiroshi
Jadad
Lane
Lechat
Lip
Morocutti
Olsson
Patrono
Petersen
PĂ©rez-GĂłmez
Raju
Sam
Singer
The Active Investigators
The Boston Area Antigoagualtion Trial for Atrial Fibrillation Investigators
The European Atrial Fibrillation Trial Study Group
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
The Stroke Prevention in Atrial Fibrillation Investigators
van Walraven
Wolf
Wolfe
Yamaguchi
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Transesophageal echocardiography and stroke
Author
A Boon
A Das
+45Â more
A Mugge
AC Pearson
AL Klein
B Brenner
B Schneider
C Pollick
D Barbut
D Gilon
DA Orsinelli
DG Karalis
DG Karalis
E Ferrari
ES Katz
FA Dressler
GD Birmingham
IW Black
JH Lichtman
JK Roberts
JL Mas
JR Overell
LR Rogers
M Zabalgoitia
P Amarenco
P Siostrzonek
P Szekely
P Vaduganathan
PA Tunick
PA Wolf
PT Hagen
RA Asherson
RF Schroeckenstein
RG Hart
RR Kasliwal
S Homma
S Homma
SPAF III Investigators
SPAF III Investigators
T Mooe
T Mooe
The Cerebral Embolism Task Force
Timothy D. Woods
WG Daniel
WG Daniel
WJ Manning
Y Agmon
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation
Author
Atrial Fibrillation Investigators
Atrial Fibrillation Investigators
+33Â more
Blackshear
Camm
Dagres
Davies
Deirdre A. Lane
Diener
Eckman
Fang
Friberg
Frost
Fuster
Gage
Gorin
Gregory Y.H. Lip
Hart
Hart
Ho
Hughes
Jonas Bjerring Olesen
Laurent Fauchier
Lip
Lip
Lip
Marinigh
Olesen
Pencina
Singer
Sophie Taillandier
Stroke Risk in Atrial Fibrillation Working Group
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
The Stroke Prevention in Atrial Fibrillation Investigators
The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography
van Walraven
Publication venue
'American College of Chest Physicians'
Publication date
Field of study
No full text
Crossref
Anticoagulation for Non-Valvular Atrial Fibrillation in Older People
Author
Albers
Anon.
+54Â more
Bauer
Benjamin
Brass
Breckenridge
Cabral
Connolly
Connolly
Connolly
Connolly
Conway
Eikelboom
Fang
Fang
Flaker
Fuster
Gage
Gage
Garwood
Granger
Harper
Hart
Hart
Heeringa
Hirsh
Howard
Hylek
Hylek
Hylek
Hylek
Kopecky
Lip
Lip
Man-Son-Hing
Mant
Marinigh
Naccarelli
Nieuwlaat
Olesen
Olsson
Patel
Pisters
Poli
Poli
Psaty
Rash
Ruff
Stangier
Stewart
Sturm
Tay
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
Walraven
Wang
Wolf
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Anticoagulants for atrial fibrillation: Why is the treatment rate so low?
Author
Adhiyaman
Albers
+60Â more
Albers
Antani
Bar-Sela
Bath
Beyth
Brass
Brodsky
Bungard
Callegari
Carlsson
Chang
Connolly
Denham
EAFT (European Atrial Fibrillation Trial) Study Group
Ezekowitz
Feinberg
Flaker
Fuster
Gage
Gaughan
Gottlieb
Gottlieb
Gurwitz
Gustafsson
Hart
Hart
Hart
Hendry
Hohnloser
Kutner
Laupacis
Lip
Lip
Lip
Man-Son-Hing
McCrory
Mendelson
Monette
Munschauer
O'Connell
Olsson
Pearce
Petersen
Prystowsky
Pubentz
Rodgers
Seidl
Stafford
Stroke Prevention in Atrial Fibrillation III randomised clinical trial
Stroke Prevention in Atrial Fibrillation Study
Sudlow
Sweeney
Taylor
The Atrial Fibrillation Investigators
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
The Clinical Quality Improvement Network (CQIN) Investigators
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography
Whittle
Wolf
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Estimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials
Author
AC Spyropoulos
Alpesh Amin
+39Â more
AR Harrington
AS Go
Atrial Fibrillation Investigators
CB Granger
CJ Mercaldi
Daniel Wiederkehr
DE Singer
Dinara Makenbaeva
E Birman-Deych
E Chiquette
EM Hylek
GV Naccarelli
HD White
J Ansell
Jay Lin
JE Ansell
JJ Caro
John Graham
L Wallentin
L Wallentin
LK Gottlieb
MC Fang
MH Kim
MR Patel
NJ Veeger
RG Hart
S Connolly
S Deitelzweig
SJ Connolly
SJ Connolly
SR Earnshaw
Steve Deitelzweig
SV Sorensen
T Miura
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
V Fuster
WL Baker
Y Miyasaka
Yonghua Jing
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
1
2
3